The global benidipine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Benidipine is a synthetic dihydropyridine calcium channel blocker used to treat hypertension and angina pectoris. The major factor expected to drive the market growth is the rising prevalence of cardiovascular disorders. It is used for the treatment of CVD such as hypertension, reno parenchymal hypertension, and angina pectoris. Hypertension (high blood pressure) is a lifelong or chronic condition in which the blood pressure against the artery walls becomes high and angina-pectoris is a type of chest pain caused by reduced blood flow to the heart. There is a significant rise in the incidence of hypertension globally. For instance, by September 2019, around 1.1 billion people globally have hypertension according to World Health Organization (WHO) data, most living in middle and low-income countries.
Benidipine reduces systolic and diastolic blood pressure as well as decreases heart rate pulse after treatment and also decreases urinary protein excretion and serum triglycerides. Additionally, many studies show that benidipine has anti-oxidative activity and features suppression of adhesion molecules expression, stimulation of osteoblast differentiation, suppression of the proliferation of vascular smooth muscle cells and mesangial cells, as well as myocardial protection. Additionally, in several basic and clinical studies, it is found that benidipine (CAS 91599-74-5) has been reported as an effective antihypertensive treatment. Some major players in the market include Novartis International AG, and Mylan NV, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Benidipine Market at: https://orionmarketreports.com/request-sample/?id=96527&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Novartis International AG, and Mylan NV, among others.
A full report Benidipine Market of is available at: https://orionmarketreports.com/benidipine-market/96527/
Global Benidipine Market Report by Segment
By Type
- 2 Mg Tablets
- 4 Mg Tablets
- 8 Mg Tablet
By Application
- Hypertension
- Reno Parenchymal Hypertension
- Angina Pectoris
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
